Sarepta Up 12% As FDA Is 'Actively Engaged' On Drug Application
July 30, 2014 at 11:33 AM EDT
Sarepta Therapeutics (NASDAQ: SRPT) opened sharply higher after the Food and Drug Administration made favorable noises about the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.